Orgenesis Inc (ORGS)
0.5072
+0.01
(+1.26%)
USD |
NASDAQ |
Apr 22, 16:00
Orgenesis Market Cap: 17.42M for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 17.42M |
| April 19, 2024 | 17.20M |
| April 18, 2024 | 17.58M |
| April 17, 2024 | 17.48M |
| April 16, 2024 | 17.17M |
| April 15, 2024 | 17.16M |
| April 12, 2024 | 16.84M |
| April 11, 2024 | 19.11M |
| April 10, 2024 | 17.89M |
| April 09, 2024 | 16.56M |
| April 08, 2024 | 16.22M |
| April 05, 2024 | 17.72M |
| April 04, 2024 | 19.81M |
| April 03, 2024 | 16.91M |
| April 02, 2024 | 13.20M |
| April 01, 2024 | 19.84M |
| March 28, 2024 | 28.07M |
| March 27, 2024 | 29.03M |
| March 26, 2024 | 29.06M |
| March 25, 2024 | 30.70M |
| March 22, 2024 | 30.70M |
| March 21, 2024 | 29.71M |
| March 20, 2024 | 30.73M |
| March 19, 2024 | 30.05M |
| March 18, 2024 | 29.92M |
| Date | Value |
|---|---|
| March 15, 2024 | 26.95M |
| March 14, 2024 | 26.50M |
| March 13, 2024 | 30.48M |
| March 12, 2024 | 29.37M |
| March 11, 2024 | 28.06M |
| March 08, 2024 | 29.28M |
| March 07, 2024 | 28.65M |
| March 06, 2024 | 28.38M |
| March 05, 2024 | 28.06M |
| March 04, 2024 | 24.45M |
| March 01, 2024 | 21.71M |
| February 29, 2024 | 20.41M |
| February 28, 2024 | 19.86M |
| February 27, 2024 | 19.13M |
| February 26, 2024 | 20.08M |
| February 23, 2024 | 18.81M |
| February 22, 2024 | 15.35M |
| February 21, 2024 | 14.98M |
| February 20, 2024 | 13.04M |
| February 16, 2024 | 12.75M |
| February 15, 2024 | 15.30M |
| February 14, 2024 | 10.87M |
| February 13, 2024 | 9.436M |
| February 12, 2024 | 9.531M |
| February 09, 2024 | 9.554M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.999M
Minimum
Jan 19 2024
195.53M
Maximum
Mar 12 2021
75.28M
Average
69.93M
Median
Dec 31 2021
Market Cap Benchmarks
| Altimmune Inc | 556.53M |
| Verastem Inc | 245.48M |
| Oragenics Inc | 4.660M |
| Actinium Pharmaceuticals Inc | 210.77M |
| Dare Bioscience Inc | 31.68M |
Market Cap Related Metrics
| PEG Ratio | -0.0006 |
| Price | 0.5072 |
| Earnings Yield | -514.6% |
| PEGY Ratio | -0.0006 |